Publications
- Complex genetic and histopathological study of 15 patient-derived xenografts of aggressive lymphomas2022 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Pilsen, Faculty of Physical Education and Sport
- Anti-apoptotic MCL1 Protein Represents Critical Survival Molecule for Most Burkitt Lymphomas and BCL2-negative Diffuse Large B-cell Lymphomas2022 | First Faculty of Medicine
- Sequencing-based analysis of clonal evolution of 25 mantle cell lymphoma patients at diagnosis and after failure of standard immunochemotherapy2023 | First Faculty of Medicine, Second Faculty of Medicine
- Circulating microRNAs in Cerebrospinal Fluid and Plasma: Sensitive Tool for Detection of Secondary CNS Involvement, Monitoring of Therapy and Prediction of CNS Relapse in Aggressive B-NHL Lymphomas2022 | Central Library of Charles University, First Faculty of Medicine, Faculty of Mathematics and Physics, Third Faculty of Medicine
- CD31/PECAM-1 impacts engraftment, growth and spread of mantle cell lymphoma cells and positively correlates with extramedullary involvement2021 | First Faculty of Medicine
- Drug Resistance in Non-Hodgkin Lymphomas2020 | First Faculty of Medicine
- BCL-2 Proteins in Pathogenesis and Therapy of B-Cell Non-Hodgkin Lymphomas2020 | First Faculty of Medicine
- Prognostic impact of somatic mutations in diffuse large B-cell lymphoma and relationship to cell-of-origin: data from the phase III GOYA study2020 | First Faculty of Medicine
- Cotargeting of BCL2 with venetoclax and MCL1 with S63845 is synthetically lethal in vivo in relapsed mantle cell lymphoma2019 | First Faculty of Medicine, Second Faculty of Medicine
- Integration of cell of origin into the clinical CNS International Prognostic Index improves CNS relapse prediction in DLBCL2019 | First Faculty of Medicine
Loading network view...